Travere Therapeutics Inc.

TVTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$61.37

-$1.49 (-2.37%)

Sep 22, 2026, 11:26 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-25.55M	-320.63M	-376.33M	-331.47M	-217.29M	-169.43M
Depreciation & Amortization	60.74M	43.56M	38.53M	20.72M	12.75M	24.58M
Stock-Based Compensation	44.87M	36.91M	44.25M	38.14M	29.57M	23.61M
Other Working Capital	8.89M	-35.64M	481K	1.46M	60.24M	-17.24M
Other Non-Cash Items	-28.28M	65.71M	39.01M	85.44M	79.41M	102.54M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	1.99M
Change in Working Capital	-14M	-63.02M	-25.48M	875K	80.78M	-26.04M
Operating Cash Flow	37.78M	-237.48M	-280.02M	-186.29M	-14.79M	-42.74M
Capital Expenditures	-58.16M	-101.21M	-41.59M	-28.37M	-24.15M	-119.85M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	113.08M
Purchase of Investments	-237.14M	-125.76M	-443.94M	-385.39M	-547.08M	-214.96M
Sales Maturities Of Investments	323.6M	326.33M	334.58M	381.99M	433.6M	273.48M
Other Investing Acitivies	-404K	-40K	165.81M	-28.97M	-19.05M	-113.08M
Investing Cash Flow	27.89M	99.33M	55.78M	-32.55M	-137.62M	-61.33M
Debt Repayment	-68.9M	n/a	n/a	104.93M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-2.1M	4.68M	27.55M	-6.9M	6.75M	-3.81M
Financial Cash Flow	-33.47M	139.42M	218.75M	117.57M	231.68M	127.71M
Net Cash Flow	34.5M	359K	-3.51M	-104.07M	80.98M	22.34M
Free Cash Flow	-20.37M	-338.69M	-321.61M	-214.66M	-38.94M	-162.59M
Adj. Free Cash Flow	-65.24M	-375.6M	-365.86M	-252.8M	-68.51M	-186.2M
Maintenance CapEx	-33.27M	-91.19M	-37.76M	-28.37M	-24.15M	-119.14M
Growth CapEx	-24.89M	-10.02M	-3.83M	n/a	n/a	-706.96K
Owner Earnings	4.52M	-328.66M	-317.78M	-214.66M	-38.94M	-161.88M